USPSTF Urges Interventions to Prevent Tobacco Use in Children
TUESDAY, June 25, 2019 -- The U.S. Preventive Services Task Force (USPSTF) recommends that primary care physicians provide interventions to prevent school-aged children and adolescents from initiating tobacco use. This recommendation forms the basis of a draft recommendation statement, published online June 25 by the USPSTF.
Shelley Selph, M.D., M.P.H., from the Oregon Health & Science University in Portland, and colleagues conducted a systematic review to update the 2013 USPSTF review on primary care-relevant interventions for tobacco use prevention and cessation in children and adolescents. For this review, electronic nicotine delivery systems were included. Twenty-seven trials met the inclusion criteria.
The researchers found that compared with control interventions, behavioral interventions correlated with a reduced likelihood of smoking initiation. In trials restricted to smokers, behavioral interventions did not affect smoking prevalence. In trials of smokers and nonsmokers, behavioral interventions were more effective than control interventions for reducing smoking prevalence. Based on these findings, the USPSTF concludes that primary care clinicians should provide interventions, including education or brief counseling, to prevent initiation of tobacco use among children and adolescents (B recommendation). The current evidence is inadequate for assessing the balance of benefits and harms of primary care-feasible interventions for tobacco use cessation among children and adolescents (I statement).
The draft recommendation statement and evidence review have been posted for public comment. Comments can be submitted from June 25 to July 22, 2019.
© 2020 HealthDay. All rights reserved.
Posted: June 2019
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.